![Colin Walsh](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Colin Walsh
Directeur/Bestuurslid bij Ceptur Therapeutics, Inc.
Oorsprong van het eerstegraads netwerk van Colin Walsh
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Korro Bio, Inc.
![]() Korro Bio, Inc. BiotechnologyHealth Technology Korro Bio, Inc. engages in the development of a bio therapeutics. It focuses on a proprietary platform designed to selectively edit messenger RNA and recode specific codons to effect changes in protein structure and function across multiple tissues. The company was founded by Jean-Fran?ois Formela, Josh Rosenthal, Nessan Bermingham, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA.
11
| Subsidiary | Biotechnology | 11 |
Public Company | Biotechnology | 10 | |
Element Science, Inc.
![]() Element Science, Inc. Electronic Equipment/InstrumentsElectronic Technology Element Science, Inc. operates as a medical device and digital health company. It develops a wearable platform solution with proprietary technology in wearable patches, electrical design, machine learning algorithms and digital solutions. The company was founded by Uday N. Kumar in 2011 and is headquartered in San Francisco, CA.
8
| Holding Company | Electronic Equipment/Instruments | 8 |
Qiming US Ventures Management, LLC
![]() Qiming US Ventures Management, LLC Investment ManagersFinance Qiming US Ventures Management LLC (Qiming Venture Partners) is a venture capital subsidiary of Qiming Venture Partners Ltd founded in 2017 by Mark D. McDade and Gary Edward Rieschel. The firm is headquartered in Cambridge, Massachusetts.
8
| Subsidiary | Investment Managers | 8 |
Ceptur Therapeutics, Inc.
![]() Ceptur Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Ceptur Therapeutics, Inc. is a company that focuses on developing medicines for severe diseases in the areas of oncology, the central nervous system, nephrology, and immunology. The company is based in Hillsborough, NJ and has subsidiaries in the United States. The company is revolutionizing RNA therapeutics with U1 adaptor technology to address unaddressed diseases. The company was founded by Rafal Goraczniak and P. Peter Ghoroghchian, with P. Peter Ghoroghchian serving as CEO since incorporation.
7
| Holding Company | Pharmaceuticals: Other | 7 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Colin Walsh via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Millennium Pharmaceuticals, Inc.
![]() Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
FlowMetric LLC
![]() FlowMetric LLC Medical/Nursing ServicesHealth Services FlowMetric, Inc. provides flow cytometry and cell sorting services. It serves partners in multiple fields including biotechnology, small and large cap pharmaceuticals, hospitals and academic institutions. The firm provides flow cytometry, pre-clinical, pre-clinical toxicology and safety, clinical, cell sorting, monoclonal antibody production, and agri-food services. The company was founded by Renold Capocasale in 2010 and is headquartered in Doylestown, PA. | Medical/Nursing Services | Corporate Officer/Principal | |
OnKure, Inc.
![]() OnKure, Inc. BiotechnologyHealth Technology OnKure, Inc. engages in the discovery and development of epigenetic therapies for the treatment of cancer. It develops selective inhibitors of histone deacetylases in preclinical models of both hematological and solid tumor cancers. The company was founded by Xuedong Liu and Anthony D. Piscopio in April 2011 and is headquartered in Longmont, CO. | Biotechnology | Director/Board Member Director/Board Member | |
TRANSLATE BIO, INC. | Biotechnology | Founder Founder | |
Navitor Pharmaceuticals, Inc.
![]() Navitor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Navitor Pharmaceuticals, Inc. develops medicine for age-related diseases. Its drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth. The company was founded by Alan L. Crane, David Sabatini and David Goldfarb and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Duke University
![]() Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Graduate Degree | |
Stanford University | College/University | Undergraduate Degree Graduate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
University of Pennsylvania | College/University | Doctorate Degree Undergraduate Degree | |
University of Cambridge | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
Atlas Venture Advisors, Inc.
![]() Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor Director of Finance/CFO Consultant / Advisor | |
Emory University | College/University | Doctorate Degree | |
NEA Management Co. LLC
![]() NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
The University of Chicago | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree | |
Cornell University
![]() Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Masters Business Admin | |
University of Mumbai | College/University | Undergraduate Degree | |
E2 Consulting Engineers, Inc.
![]() E2 Consulting Engineers, Inc. Miscellaneous Commercial ServicesCommercial Services E2 Consulting Engineers, Inc. provides consulting services. It offers facilities, Infrastructure, project controls, engineering, ecological, environmental modeling, waste water engineering and waste management services. The company was founded in 1988 and it is headquartered in Denver, CO. | Miscellaneous Commercial Services | Director of Finance/CFO | |
venBio Partners LLC
![]() venBio Partners LLC Investment ManagersFinance venBio Partners LLC (venBio) is a venture capital subsidiary of Venbio Partners LP founded in 2009 by Adelman robert and Goodman corey. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
VERASTEM, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Cibiem, Inc.
![]() Cibiem, Inc. Medical SpecialtiesHealth Technology Cibiem, Inc. operates as a medical device company. Its catheter-based approach focuses on carotid body modulation for the treatment of sympathetic nervous system-mediated diseases such as hypertension, heart failure, diabetes, and renal failure. The company was founded by Mark Gelfand and Howard R. Levin and is headquartered in Los Altos, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
INTELLIA THERAPEUTICS, INC. | Biotechnology | Founder Founder | |
Deerfield Management Co. LP (Private Equity)
![]() Deerfield Management Co. LP (Private Equity) Investment ManagersFinance Deerfield Management Co. LP (Private Equity) (Deerfield) is a private equity subsidiary of Deerfield Management Co. LP founded in 1994. The firm is headquartered in the New York. | Investment Managers | Private Equity Investor | |
Atlas Venture Life Science Advisors LLC
![]() Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Director of Finance/CFO | |
Corvidia Therapeutics, Inc.
![]() Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member Founder | |
PLIANT THERAPEUTICS, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
XILIO THERAPEUTICS, INC. | Pharmaceuticals: Major | President Chairman | |
OYSR POIN | Pharmaceuticals: Major | Chairman Director/Board Member | |
Medical Microinstruments SpA
![]() Medical Microinstruments SpA Medical SpecialtiesHealth Technology Medical Microinstruments SpA develops and manufactures surgical micro-instruments. The firm focuses on clinical outcomes for patients undergoing microsurgery, and offers advanced microsurgical procedures, while reducing costs for patients, hospitals and for society at large. The company was founded by Giuseppe Prisco, Hannah Teichmann and Massimiliano Simi in 2015 and is headquartered in Calci, Italy. | Medical Specialties | Director/Board Member | |
AKERO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
DYNE THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
F-star Therapeutics Ltd.
![]() F-star Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology F-Star Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of immune-oncology drugs for antibody therapies. The company was founded in 2006 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Silagene, Inc.
![]() Silagene, Inc. Medical/Nursing ServicesHealth Services Silagene, Inc. provides health care services. The company is headquartered in Hillsborough, NJ. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
VENTYX BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
RAYZEBIO, INC. | Biotechnology | Founder Founder | |
Avidea Technologies, Inc.
![]() Avidea Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Vaccitech Plc, Avidea Technologies, Inc. is a biotechnology company based in Baltimore, MD. Avidea is advancing the next generation of safer and more effective T cell immunotherapies for treating cancer, infections, and autoimmune diseases. The company's precision immunotherapies are enabled by polymer-drug conjugate technologies, which are purpose-built to address the need for improved T cell and antibody-based immunotherapies. The company was founded by Geoffrey Lynn and Andrew Ishizuka, and Geoffrey Lynn has been the CEO since incorporation. Avidea was acquired by Vaccitech Plc on December 13, 2021 for $40 million. | Miscellaneous Commercial Services | Director/Board Member | |
Pleno, Inc.
![]() Pleno, Inc. Internet Software/ServicesTechnology Services Pleno, Inc. is a company that specializes in multi-omic instrument platform technology for clinical testing and biomedical research. The company is based in San Diego, CA and was founded by Pieter van Rooyen, who has been the CEO since incorporation. The company's proprietary hypercoding™ technology uses signal processing techniques to provide targeted biological information with exceptional scale, precision, and performance. | Internet Software/Services | Director/Board Member | |
Aurion Biotech, Inc.
![]() Aurion Biotech, Inc. Medical/Nursing ServicesHealth Services Aurion Biotech, Inc. is a clinical-stage biotech company with offices in multiple locations. Aurion Biotech has initiated clinical trials in the US in 2023. The company is based in Seattle, WA. The company's mission is to restore vision to millions of patients with life-changing regenerative therapies. Aurion Biotech has received the prestigious Prix Galien award for best start-up in biotech. The company's first candidate is an off-the-shelf, clinically validated cell therapy for corneal care, which has received regulatory approval. The company is privately held and backed by leading investors, including Deerfield, Alcon, Petrichor, Flying L Partners, Falcon Vision/KKR, and Visionary Ventures. Greg Kunst has been the CEO of the company since 2021. | Medical/Nursing Services | Director/Board Member | |
35Pharma, Inc.
![]() 35Pharma, Inc. Pharmaceuticals: MajorHealth Technology 35Pharma, Inc. designs and develops biologics for diseases of high unmet medical need. The CEO of the Canadian company is Ilia A. Tikhomirov. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Nexo Therapeutics, Inc.
![]() Nexo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nexo Therapeutics is a small molecule oncology company that focuses on discovering and developing new drugs for cancer patients who do not have effective treatments. The company is based in Littleton, CO and Watertown, MA. The company uses covalent ligand discovery, chemical biology, cancer biology, and medicinal chemistry to target the underlying causes of cancer through innovative methods. Nexo Therapeutics was founded by John Athanosopoulos, Andrew J. Phillips, Michael Kim, and Rhamy Zeid. Andrew J. Phillips has been the CEO of the company since 2022. | Pharmaceuticals: Major | Director/Board Member Founder | |
Tourmaline Bio, Inc.
![]() Tourmaline Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Tourmaline Bio, Inc., Tourmaline Sub, Inc. is a late-stage clinical biotechnology company based in New York, NY. The company's lead program, Tour006, is an anti-IL-6 antibody with high binding affinity and a naturally long half-life. Tour006 has been studied in over 400 autoimmune patients across six clinical trials. Tourmaline Sub plans to develop Tour006 for thyroid eye disease (TED) and atherosclerotic cardiovascular disease (ASCVD), with additional indications being considered. The company, founded in 2021 by Sandeep Kulkarni and Caley M. Castelein, is focused on developing transformative medicines for patients with life-altering immune diseases. Sandeep Kulkarni has been the CEO since 2021. Tourmaline Sub was acquired by Talaris Therapeutics, Inc. on October 19, 2023, for $43.50 million. | Miscellaneous Commercial Services | Director/Board Member Director of Finance/CFO |
Statistieken
Internationaal
Verenigde Staten | 41 |
Verenigd Koninkrijk | 3 |
India | 2 |
China | 2 |
Italië | 2 |
Sectoraal
Health Technology | 23 |
Consumer Services | 11 |
Finance | 6 |
Health Services | 5 |
Commercial Services | 4 |
Operationeel
Director/Board Member | 279 |
Corporate Officer/Principal | 79 |
Independent Dir/Board Member | 52 |
Director of Finance/CFO | 39 |
Founder | 38 |
Sterkste connecties
Insiders | |
---|---|
Jean-Francois Formela | 48 |
Nessan Bermingham | 36 |
Ali Behbahani | 35 |
Neil Exter | 33 |
Andrew ElBardissi | 32 |
Russell C. Hirsch | 31 |
Andrew Phillips | 23 |
Aaron Royston | 19 |
Aaron Kantoff | 19 |
Eric J. Hall | 18 |
Richard Gaster | 17 |
Isaac E. Ciechanover | 16 |
R. Carruthers | 15 |
Ben Tsai | 12 |
Ram Aiyar | 12 |
- Beurs
- Insiders
- Colin Walsh
- Bedrijfsconnecties